Oramed Pharmaceuticals
ORMP
#9104
Rank
C$0.12 B
Marketcap
$2.99
Share price
-2.78%
Change (1 day)
-15.83%
Change (1 year)

Earnings for Oramed Pharmaceuticals (ORMP)

Earnings in 2024 (TTM): C$33.14 Million

According to Oramed Pharmaceuticals's latest financial reports the company's current earnings are N/A. In 2023 the company made an earning of C$10.13 Million, an increase over its 2022 earnings that were of -C$52.08 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Oramed Pharmaceuticals from 2006 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) C$33.14 M227.19%
2023 C$10.13 M-119.45%
2022 -C$52.08 Million39.17%
2021 -C$37.43 Million73.93%
2020 -C$21.52 Million18.53%
2019 -C$18.16 Million-16.62%
2018 -C$21.77 Million38.32%
2017 -C$15.74 Million12.51%
2016 -C$13.99 Million25.01%
2015 -C$11.19 Million18.18%
2014 -C$9.47 Million39.72%
2013 -C$6.78 Million46.4%
2012 -C$4.63 Million128.32%
2011 -C$2.03 Million-51.47%
2010 -C$4.18 Million35.21%
2009 -C$3.09 Million
2007 -C$4.86 Million607.04%
2006 -C$0.69 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-C$0.72 Billion-2,147.42%๐Ÿ‡บ๐Ÿ‡ธ USA
C$26.92 B 76,757.93%๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark
C$11.29 B 32,128.38%๐Ÿ‡ซ๐Ÿ‡ท France
-C$13.81 Million-139.40%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
-C$0.29 Billion-913.22%๐Ÿ‡บ๐Ÿ‡ธ USA